| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:jnce | nasdaq:jnce Shareholders | 13F-HR | 0001567619-22-010177 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | BESSEMER GROUP INC | 1054074 | JOUNCE THERAPEUTICS INC | SC | 481116101 | 187 | 27585 | SH | DFND | 5 | 0 | 0 | 27585 | May 13th, 2022 01:31AM | May 13th, 2022 01:31AM | Jounce Therapeutics | |||
| nasdaq:jnce | nasdaq:jnce Shareholders | 13F-HR | 0001567619-22-010159 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | FIDUCIARY TRUST CO | 35442 | JOUNCE THERAPEUTICS INC | COM | 481116101 | 144 | 21185 | SH | SOLE | 21185 | 0 | 0 | May 13th, 2022 01:31AM | May 13th, 2022 01:31AM | Jounce Therapeutics | ||||
| nasdaq:jnce | nasdaq:jnce Shareholders | 13F-HR | 0001533421-22-000004 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | Tower Research Capital LLC (TRC) | 1533421 | JOUNCE THERAPEUTICS INC | COM | 481116101 | 14 | 2082 | SH | DFND | 2 | 2082 | 0 | 0 | May 13th, 2022 01:30AM | May 13th, 2022 01:30AM | Jounce Therapeutics | |||
| nasdaq:jnce | nasdaq:jnce Shareholders | 13F-HR | 0001172661-22-001240 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | PANAGORA ASSET MANAGEMENT INC | 883677 | JOUNCE THERAPEUTICS INC | COM | 481116101 | 838 | 123351 | SH | SOLE | 23868 | 0 | 99483 | May 13th, 2022 01:28AM | May 13th, 2022 01:28AM | Jounce Therapeutics | ||||
| nasdaq:jnce | nasdaq:jnce Shareholders | 13F-HR | 0001115418-22-000003 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | RHUMBLINE ADVISERS | 1115418 | JOUNCE THERAPEUTICS INC | COM | 481116101 | 292 | 43035 | SH | SOLE | 18103 | 0 | 24932 | May 13th, 2022 01:28AM | May 13th, 2022 01:28AM | Jounce Therapeutics | ||||
| nasdaq:jnce | nasdaq:jnce Shareholders | 13F-HR | 0000932540-22-000002 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | GROUP ONE TRADING, L.P. | 932540 | JOUNCE THERAPEUTICS INC | COM | 481116101 | 15 | 2250 | SH | SOLE | 2250 | 0 | 0 | May 13th, 2022 01:24AM | May 13th, 2022 01:24AM | Jounce Therapeutics | ||||
| nasdaq:jnce | nasdaq:jnce Shareholders | 13F-HR | 0000834237-22-009651 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | BlackRock Inc. | 1364742 | JOUNCE THERAPEUTICS INC | COM | 481116101 | 29 | 4229 | SH | SOLE | 43 | 4170 | 0 | 59 | May 13th, 2022 01:21AM | May 13th, 2022 01:21AM | Jounce Therapeutics | |||
| nasdaq:jnce | nasdaq:jnce Shareholders | 13F-HR | 0000834237-22-009651 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | BlackRock Inc. | 1364742 | JOUNCE THERAPEUTICS INC | COM | 481116101 | 173 | 25416 | SH | SOLE | 30 | 25416 | 0 | 0 | May 13th, 2022 01:21AM | May 13th, 2022 01:21AM | Jounce Therapeutics | |||
| nasdaq:jnce | nasdaq:jnce Shareholders | 13F-HR | 0000834237-22-009651 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | BlackRock Inc. | 1364742 | JOUNCE THERAPEUTICS INC | COM | 481116101 | 5125 | 754744 | SH | SOLE | 22 | 735934 | 0 | 18810 | May 13th, 2022 01:21AM | May 13th, 2022 01:21AM | Jounce Therapeutics | |||
| nasdaq:jnce | nasdaq:jnce Shareholders | 13F-HR | 0000834237-22-009651 | Mar 31st, 2022 12:00AM | May 12th, 2022 12:00AM | May 12th, 2022 12:00AM | BlackRock Inc. | 1364742 | JOUNCE THERAPEUTICS INC | COM | 481116101 | 10067 | 1482579 | SH | SOLE | 21 | 1482579 | 0 | 0 | May 13th, 2022 01:21AM | May 13th, 2022 01:21AM | Jounce Therapeutics |